Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antihypertensive therapy and endothelial function.

Sunil Nadar1, Andrew D Blann, Gregory Y H Lip

  • 1Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK.

Current Pharmaceutical Design
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Von Willebrand factor antigen levels predict major adverse cardiovascular events in patients with carotid stenosis of the ICARAS study.

Atherosclerosis·2019
Same author

Net Clinical Benefit of Edoxaban for Stroke, Mortality, and Bleeding Risk: Modeling Projections for a European Population.

JACC. Clinical electrophysiology·2018
Same author

Modelling projections for the uptake of edoxaban in an European population to 2050: effects on stroke, thromboembolism, and health economics perspectives.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2016
Same author

Relationship between renal function and circulating microparticles, soluble P-selectin and E-selectin levels in atrial fibrillation.

Journal of thrombosis and thrombolysis·2016
Same author

Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease.

Journal of the American College of Cardiology·2016
Same author

Effects of non-vitamin K antagonist oral anticoagulants on fibrin clot and whole blood clot formation, integrity and thrombolysis in patients with atrial fibrillation.

Journal of thrombosis and thrombolysis·2016

Treating hypertension reduces cardiovascular events, but some drugs offer benefits beyond lowering blood pressure. Calcium channel blockers and ACE inhibitors directly improve endothelial function, unlike beta and alpha blockers.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Hypertension treatment's benefits in reducing morbidity and mortality are established.
  • The precise mechanisms, whether solely due to blood pressure reduction or additional endothelial effects, remain debated.
  • Endothelial dysfunction in hypertension is a key predictor of cardiovascular events.

Purpose of the Study:

  • To investigate whether antihypertensive agents provide benefits beyond blood pressure reduction.
  • To explore the direct and indirect effects of different drug classes on endothelial function in hypertension.

Main Methods:

  • Review of existing literature on hypertension pharmacotherapy and endothelial function.
  • Comparative analysis of drug classes including calcium channel blockers, ACE inhibitors, beta blockers, and alpha adrenergic blockers.

Related Experiment Videos

  • Examination of the role of antioxidants in endothelial function.

    • Main Results:

    • Calcium channel blockers and ACE inhibitors demonstrate direct positive effects on the endothelium.
    • Beta blockers and alpha adrenergic blockers appear to influence endothelial function indirectly through blood pressure reduction.
    • Antioxidants show potential for improving endothelial function, but clinical benefits are not consistently observed.

    Conclusions:

    • Antihypertensive medications may offer dual benefits: blood pressure reduction and direct endothelial protection.
    • Drug selection in hypertension management should consider potential direct vascular effects.
    • Further research is needed to clarify the clinical utility of agents with direct endothelial effects.